| Literature DB >> 32992629 |
Maria Angiola Crivellaro1, Giancarlo Ottaviano2, Pietro Maculan1, Alfonso Luca Pendolino3, Liviano Vianello4, Paola Mason1, Francesco Gioffrè5, Rosana Bizzotto5, Bruno Scarpa6,7, Edi Simoni2, Laura Astolfi2, Piero Maestrelli1, Maria Luisa Scapellato1, Mariella Carrieri1, Andrea Trevisan1.
Abstract
A group of 142 bakers was studied in order to investigate the relationship between higher/lower respiratory signs/symptoms and inflammation biomarkers and occupational exposure to flour dust. A complete upper and lower respiratory tract evaluation was performed. Seven percent of bakers complained of lower respiratory symptoms, while 22% of them complained of upper respiratory symptoms. Fifty five percent of the bakers were allergic, and 37.1% showed sensitization to occupational allergens. Abnormal spirometries were found in 15% of bakers, while fractional exhaled nitric oxide (FeNO) was above the normal reference in 24.5% of them. Moreover, 23.8% of bakers were found to be hyposmic. Population mean peak nasal inspiratory flow (PNIF) was in the normal range even if almost all the workers suffered from neutrophilic rhinitis at nasal cytology with the number of nasal neutrophils increasing with the increase of the duration of exposure to flour dust (p = 0.03). PNIF and FEV1 (forced expiratory volume in the 1st second) showed a positive correlation (p = 0.03; r = 0.19). The Tiffeneau index decreased with the increase of dust (p = 0.017). A similar result was obtained once we divided our population into smokers and non-smokers (p = 0.021). Long-term exposure to bakery dusts can lead to a status of minimal nasal inflammation and allergy.Entities:
Keywords: PNIF; Tiffeneau index; flour dust; nasal cytology; occupational exposure; skin prick test; smell
Mesh:
Substances:
Year: 2020 PMID: 32992629 PMCID: PMC7579018 DOI: 10.3390/ijerph17197075
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Main participants’ characteristics.
| Overall (N = 142) | ||
|---|---|---|
| Demographic Characteristics | N (%) | mean (SD) |
| Age (years) | 39.9 (11.3) | |
| Sex | ||
| Male | 98 (69.0) | 39.9 (12.2) |
| Female | 44 (31.0) | 39.8 (9.3) |
| Height (cm) | 175.4 (27.3) | |
| Weight (kg) | 77.3 (14.8) | |
| Body Mass Index (kg/m2) | 25.5 (4.3) | |
| Occupational Factors | ||
| Exposure time (years) | 14.1 (11.8) | |
| Personal dust concentration during working hours (mg/m3) | 2.3 (2.3) | |
| Smoking habit | ||
| Smoker | 81 (57.0) | 39.0 (12.2) |
| Non-Smoker | 61 (43.0) | 41.1 (10.0) |
Skin prick test results.
| Part A | ||
|---|---|---|
| Atopy status | Non-allergic | Allergic |
| N (%) | N (%) | |
| 63 (45.0) | 77 (55.0) | |
| Sensitization to occupational allergens | no | yes |
| N (%) | N (%) | |
| 88 (62.9) | 52 (37.1) | |
|
| ||
| Allergens | Negatives | Positives |
| N (%) | N (%) | |
|
| 75 (53.6) | 65 (46.4) |
|
| 91 (65.0) | 49 (35.0) |
|
| 98 (70.0) | 42 (30.0) |
|
| 139 (99.3) | 1 (0.7) |
| Grass mix pollen | 117 (83.6) | 23 (16.4) |
| 124 (88.6) | 16 (11.4) | |
| Birch pollen | 128 (91.4) | 12 (8.6) |
| Hazel pollen | 132 (94.3) | 8 (5.7) |
| 125 (89.3) | 15 (10.7) | |
|
| 99 (70.7) | 41 (29.3) |
|
| 121 (86.4) | 19 (13.6) |
|
| 112 (80.0) | 28 (20.0) |
|
| 112 (80.0) | 28 (20.0) |
|
| 111 (79.3) | 29 (20.7) |
|
| 114 (81.4) | 26 (18.6) |
| Corn flour | 120 (85.7) | 20 (14.3) |
| Barley flour | 134 (95.7) | 6 (4.3) |
| Rye flour | 135 (96.4) | 5 (3.6) |
| Oats flour | 135 (96.4) | 5 (3.6) |
| Wheat flour | 124 (88.6) | 16 (11.4) |
| Whole-wheat flour | 132 (94.3) | 8 (5.7) |
| Soy flour | 130 (92.9) | 10 (7.1) |
| Yeast | 136 (97.1) | 4 (2.9) |
Main lower respiratory results.
| Respiratory Findings | Mean (SD) |
|---|---|
| ACT | 24.2 (2.5) |
| Spirometry Parameters * | |
| FVC (L) | 4.4 (1.3) |
| FVC% pred. | 82.9 (24.5) |
| FEV1 (L) | 3.6 (1.1) |
| FEV1% pred. | 94.5 (54.7) |
| FEV1/FVC | 83.1 (7.2) |
| FeNO (ppb) ** | 23.7 (25.0) |
* Available for 133 subjects, ** fractional exhaled nitric oxide (FeNO) was gathered for 139 subjects, ACT: Asthma Control Test, FVC: forced vital capacity, L: liters, FEV1: forced expiratory volume in the 1st second, FEV1/FVC: Tiffeneau index.
Main upper respiratory results.
| Overall (N = 130) | ||
|---|---|---|
| Rhinological Findings | N (%) | Mean (SD) |
| PNIF (L/min) | 163.7 (49.8) | |
| Visual Analog Scale | ||
| Nasal obstruction | 2.0 (2.2) | |
| Rhinorrhea | 1.3 (2.0) | |
| Post-nasal drip | 1.0 (1.8) | |
| Frontal headache | 0.3 (1.0) | |
| Olfaction reduction | 0.9 (1.9) | |
| SNOT-22 | 14.4 (13.2) | |
| Normal | 98 (75.4) | |
| Pathologic | 32 (24.6) | |
| Screening 12 Test | 8.7 (1.9) | |
| Hyposmic * | 31 (23.8) | |
| Normosmic * | 99 (76.2) | |
| Nasal Cytology Findings ** | ||
| Neutrophils (found in 105 subjects (86.6%)) | 5.9 (5.2) | |
| Eosinophils (found in 8 subjects (6.6%)) | 0.2 (0.5) | |
| Ciliated cells (found in 66 subjects (54.5%)) | 0.7 (1.2) |
* Hyposmic: Screening 12 Test score < 8, ** performed on 121 subjects, PNIF: peak nasal inspiratory flow, SNOT-22: Sino-Nasal Outcome-22 Test.
Figure 1Flour dust levels in the different workplaces. Dust levels: mg/m3.
Figure 2Correlation between FEV1 and PNIF. PNIF: peak nasal inspiratory flow; FEV1: forced expiratory volume in the 1st second.
Figure 3Tiffeneau index (FEV1/FVC) in smokers and non-smokers.
Figure 4Nasal symptoms in smokers and non-smokers. SNOT-22: Sino-Nasal Outcome-22 Test; VAS NO: Visual Analog Scale for nasal obstruction.
Main study results.
| Independent | Dependent | Sub-Population | Means Difference | ||
|---|---|---|---|---|---|
|
| |||||
| FEV1 | - | - | 0.2 |
| |
|
| |||||
| Tiffeneau Index | - | −4.25 | - |
| |
| PNIF | - | 3.12 | - | 0.72 | |
| FEV1 | - | 0.25 | - | 0.12 | |
| FEV1% | - | −1.75 | - | 0.51 | |
| FeNO | - | −4.32 | - | 0.32 | |
| SNOT-22 | - | 6.76 | - |
| |
| Screening 12 Test | - | −0.02 | - | 0.95 | |
| VAS for nasal obstruction | - | 0.90 | - |
| |
| Number of Neutrophils at NC | - | −0.006 | - | 0.60 | |
|
| |||||
| Tiffeneau Index | - | −3.2 | - |
| |
| Smokers | −4.2 | - |
| ||
| Non-smokers | 0.04 | - | 0.54 | ||
| FEV1 | - | −0.15 | - | 0.35 | |
| FEV1% | - | −0.92 | - | 0.74 | |
| FeNO | - | −8.60 | - | 0.06 | |
| SNOT-22 | - | 0.41 | - | 0.86 | |
| Screening 12 Test | - | 0.41 | - | 0.25 | |
| VAS for nasal obstruction | - | 0.24 | - | 0.56 | |
| Number of Neutrophils at NC | - | −1.39 | - | 0.17 | |
|
| |||||
| Tiffeneau Index | - | - | −0.12 |
| |
| Smokers | - | −0.20 |
| ||
| Non-Smokers | - | 0.04 | 0.54 | ||
| Number of Neutrophils at NC | - | - | 0.15 |
| |
| PNIF | - | - | 0.13 | 0.73 | |
| FEV1 | - | - | 0.16 | 0.48 | |
| FEV1% | - | - | 0.003 | 0.81 | |
| FeNO | - | - | 0.22 | 0.22 | |
| SNOT-22 | - | - | −0.09 | 0.36 | |
| Screening 12 Test | - | - | −0.01 | 0.36 | |
| Vas for nasal Obstruction | - | - | −0.02 | 0.11 |
PNIF: peak nasal inspiratory flow; SNOT-22: Sino-Nasal Outcome-22 Test; FEV1: forced expiratory volume in the 1st second; Tiffeneau index: FEV1/FVC (FVC: forced vital capacity); FeNO: fractional exhaled nitric oxide; NC: nasal cytology; VAS: Visual Analog Scale. Significance in bold.
Figure 5On the left, the correlation between Tiffeneau index (FEV1/FVC) and exposure time for all the bakers studied (p = 0.02, r = −0.20); on the right, the correlation between Tiffeneau index (FEV1/FVC) and exposure time for the bakers who were smokers (p = 0.002, r = −0.34).
Figure 6Correlation between the number of neutrophils at nasal cytology and the exposure time.